Abel

Dr. Abel leads the Abel Lab at Dana-Farber Cancer Institute, focusing on health services research to improve care for patients with blood cancers. Their work spans geriatrics, bioethics, clinical trials, and artificial intelligence in oncology.

• Projects include the Older Adult Hematologic Malignancy (OHM) Program for functional assessment in elderly patients.
• Shared care models post-hematopoietic cell transplantation to decentralize care.
• Development of the QUALMS quality-of-life metric for MDS patients.
• Investigations into chemotherapy shortages and ethical resource allocation.

Current collaborations involve the Dieli-Conwright Lab, Hebrew SeniorLife, and OneStep Technology. The lab emphasizes patient-centered outcomes, equity in clinical trials, and AI-driven interventions like Care.coach for psychosocial support.